“a nonsignificant trend”

One RCT reported a nonsignificant trend for shorter survival when taking oral opioids compared to intrathecal opioids for pain control (6-month survival 37% versus 54%, p =0.06).

RBV after 20 min was not significantly associated with pre-dialysis ICW (R 2 = 0.03, p = 0.4) and only showed a nonsignificant trend towards correlation with ECW (R 2 = 0.14, p = 0.06; Figure 3 A–C).

Expression of VEGF-A and VEGFR-1 were unchanged ( Supplemental Figure 4 , B and C), and there was a nonsignificant trend toward increased expression of VEGFR-2 in microvessels after CTx ( Supplemental Figure 4D , P = 0.06).

For age, a nonsignificant trend was found on the CES-D at 6-month follow-up ( d =0.61 for participants older than 45 years vs d =0.09 for younger participants, F 1,280 = 3.62, P = .06), suggesting that the older group benefited more from Psyfit.

There was a trend for males to be heavier at 1 year old after a more variable early‐life; however, this effect was a nonsignificant trend ( p = .06) and so needs further investigation.

Spin rate was also greater in cases at T1 (2293.43 ± 190.34 rpm vs 2200.60 ± 198.40 rpm; P = .02), with a nonsignificant trend persisting into the index season ( P = .06).

In contrast, SMZL-LR was significantly associated with high IGHV mutational load (<97% germ line identity; P < .001; Figure 3 C) and showed a nonsignificant trend toward trisomy 12 ( P = .06).

Comparing the individual patients with the control group, even the lowest scoring patients JH and JT, who both had a C peripheral value for letters of 11, only showed a nonsignificant trend away from the control mean of 38 ( P = 0.060, Crawford and Garthwaite's test).

According to the results of the univariable analyses, a creatinine concentration ≥ 0.86 mg/dL was significantly associated with AEs (OR 4.1, 95% CI 1.58–10.7; p = 0.0037), and the incidence of decompensated cirrhosis showed a nonsignificant trend (OR 3.15; p = 0.060).

Among anti-inflammatory cytokines, only IL-4 showed a nonsignificant trend toward elevation ( p = 0.06) at 24 h (Fig. 3 A), whereas IL-10 (Fig. 3 B) and IL-13 (Fig. 3 C), and IL-2 (Fig. 3 D) – a cytokine with dual pro- [ 57 ] and anti-inflammatory roles [ 58 , 59 ] – remained unchanged throughout the time course.

ANCOVAs relating delay-period BOLD signal intensity to behavioral precision revealed significant within-subject correlations between 1O and 3O trials in both regions ( r s > 0.539; p s < 0.05), and a nonsignificant trend in this direction between 1O1C1L and 3O trials in parietal cortex ( r = 0.458; p = 0.06.

PSADT was not significantly associated with adverse biopsy findings (P=0.83), and PSAV had a nonsignificant trend (P=0.06).

For iSP ipsilateral to the right hemisphere, we observed a nonsignificant trend towards decreased inhibition in ALS patients ( p = 0.06).

Across both time points there was a significant effect of Stimulus (F[1, 34] = 45.81, p < 0.001), and a nonsignificant trend of reduced conditioning over Time (F[1, 34] = 3.81, p = 0.06).

First, there was a nonsignificant trend that age was negatively associated with target scores (i.e., more prosociality toward close others with age), F (1, 306) = 3.52, p = .06, R 2 = 0.01.

Post hoc analyses revealed a nonsignificant trend for increased food intake in HF-fed females ( day 1 , P < 0.06) and a significant increase in food intake in HF-fed males on days 1 ( P < 0.009) and 2 ( P < 0.03).

A nonsignificant trend was noted for the trained-side average AROM, (F(2,6) = 4.673, p = 0.060, η2=0.609) suggesting a potential benefit of MPWO over TOT for that measure.

johnsonii showed a nonsignificant trend in both the control and sugar groups ( P = 0.06, and P = 0.08, respectively; Fig.

There was a significant decrease in FASN of HF-PP mice and HF-PF mice compared with that of HF-V mice and a nonsignificant trend toward a reduction in ACACA compared with HF-V mice ( P = 0.06).

Although STI incidence between sites was relatively similar, there was a nonsignificant trend towards a greater incidence of multiple active STIs at the eThekwini site compared to the Tshwane site (48.9/100wy and 8.3/100wy respectively; S4 Table , p = 0.06).

For function, there was a nonsignificant trend in favor of eccentric loading in the short- (n = 3 studies; n = 144 participants; pooled MD, –7.91 [95% CI, –16 to 0.19]; P = .06) and midterm follow-up (n = 5 studies; n = 258 participants; pooled MD, –6.78 [95% CI, –14.23 to 0.68]; P = .07).

We observed a nonsignificant trend toward an improved survival in patients with brain metastases treated with TT ( P =0.06) and a significant survival benefit in those treated with IT+TT.

Overall, there was a nonsignificant trend for a negative correlation between pERK positive cell counts in the PVN and time spent interacting with the novel mouse (Spearman ρ = −0.33, p = 0.06).

In the TAF group, there was a nonsignificant trend toward improvement in lumbar spine BMD compared to TDF (predicted increase compared to TDF of 2.0% [95% CI: 0.0-- 4.0, P = 0.06], Table 2 , Figure 4Sb-c [see Figure, Supplemental Digital Content 7, lumbar spine BMD changes]). total hip BMD showed no overall change in either group (Table 2 , Figure 5Sb-c [see Figure, Supplemental Digital Content 8, total hip BMD changes]).

There was a nonsignificant trend toward higher use by the NO cohort at the 12-month follow-up [63.9% vs 54.1%, χ 2 (1) = 3.64, P = .06; data not shown].